SAM KIDANE: Open Payments
NPI 1497412399 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 8 payments from 6 companies in 2025. Trend: 2023 $974 · 2024 $735 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $53 |
| PFIZER INC. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: UBRELVY, PREVNAR 20, SHINGRIX, GARDASIL 9, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across DE — which companies pay providers there.
